Becton Dickinson and Company Stock News

Becton Dickinson (BDX) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.

Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have driven up Q1 sales.

Becton Dickinson (BDX) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Dividend Kings have an astounding track record of 50 or more years of higher dividend payouts. I rank the Dividend Kings using Quality Snapshots, a simple yet elegant system for assessing the quality

The Top Six Healthcare Products and Service companies are some of the most popular investments in the market. However, they offer varying financial profiles.

If you're looking for the best dividend stocks to buy in 2023, an excellent place to start is with the Vanguard Dividend Appreciation Index Fund  (NYSEARCA: VIG ). VIG is one of the largest U.S.-list

In 2015, I started publishing updates regarding my dividend growth portfolio, and I keep doing so every quarter. This is part of being transparent with my readers, so they can see what I hold and its

Dividend investing can work over time and anyone can create an ever growing passive income stream. My year over year progress is moving at a nice clip.

The "Halftime Report" traders give their top picks to watch for the second half.

FRANKLIN LAKES, N.J. , Jan. 6, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will host a live webcast of its

FRANKLIN LAKES, N.J. , Jan. 5, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will report financial results f

The two healthcare companies easily outdid the S&P 500 this year.

Lower lows could be ahead for investors. Here are Michael Farr's picks for the new year.

Becton, Dickinson had a flat year in 2022. Compared to the market, that was a strong result. Over the longer-term, Becton, Dickinson has been a solid compounder, but returns have lost some steam over

FRANKLIN LAKES, N.J. , Dec. 20, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the 41st Annua